Posts tagged drugs
FDA Approves Retail Availability of Qsymia Weight Loss Drug
The weight loss drug Qsymia will soon be available at retail pharmacies following approval from the Food and Drug Administration for a change to the distribution options specified in the Risk Evaluation and Mitigation Strategy (REMS). REMS are required by the FDA when drugs are potentially harmful, especially when used in ways other than intended. [...]
Read the full article →FDA Approves Two Medications for Long-Term Weight Control
The Food and Drug Administration (FDA) has approved two new weight loss drugs – marketed as Belviq and Qsymia – within the last 30 days. These are the first medications to be cleared by the FDA for marketing in the United States in 13 years. According to FDA statements, these medications aim “to help obese [...]
Read the full article →Weight Loss Drug Contrave Rejected by FDA
The FDA ruled against approving the weight loss drug Contrave in a decision that surprised many. A positive vote was expected, since an advisory panel had recommended approving the drug by a vote of 13-to-7 in December. As this decision shows, the FDA is not required to follow the advice of its expert panels. Rather, [...]
Read the full article →Orexigen Asks FDA for Approval of Contrave Weight Loss Drug
Following successful results in clinical trials with its potential weight loss drug Contrave, Orexigen Therapeutics has taken the next step for market approval and submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA). Contrave is now one of several obesity drugs that are currently awaiting FDA approval. Rather than affecting [...]
Read the full article →New Miracle Drug to Cure Obesity?
Richard DiMarchi and colleagues are taking a shot to eliminate obesity – literally. The researchers have found that a single injection of a new drug offers great potential as a pharmocological treatment for obesity. The use of drugs to induce weight loss is not new, but current methods have limited effectiveness and health risks. By [...]
Read the full article →
